𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Differentiation of myeloma and metastatic cancer in the spine using dynamic contrast-enhanced MRI

✍ Scribed by Lang, Ning; Su, Min-Ying; Yu, Hon J.; Lin, Muqing; Hamamura, Mark J.; Yuan, Huishu

Book ID
121342224
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
426 KB
Volume
31
Category
Article
ISSN
0730-725X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Comparison of dynamic contrast-enhanced
Comparison of dynamic contrast-enhanced MRI and dynamic contrast-enhanced CT biomarkers in bladder cancer
✍ J. H. Naish; D. M. McGrath; L. J. Bains; K. Passera; C. Roberts; Y. Watson; S. C πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 430 KB

## Abstract Dynamic contrast‐enhanced MRI (DCE‐MRI) is frequently used to provide response biomarkers in clinical trials of novel cancer therapeutics but assessment of their physiological accuracy is difficult. DCE‐CT provides an independent probe of similar pharmacokinetic processes and may be mod

Dynamic contrast-enhanced MRI in ovarian
Dynamic contrast-enhanced MRI in ovarian cancer: Initial experience at 3 tesla in primary and metastatic disease
✍ Andrew N. Priest; Andrew B. Gill; Masako Kataoka; Mary A. McLean; Ilse Joubert; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 196 KB

The aim of this study was to develop and demonstrate a methodology for dynamic contrast-enhanced MRI at 3 T in patients with advanced ovarian cancer and to report the results from pharmacokinetic modeling of the data. Nineteen patients with suspected advanced ovarian carcinoma (FIGO stage 3 or highe